Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for Post-Operative Pain in Minimally Invasive Sacrocolpopexy
NCT05609682Phase 1Completed
- Sponsor
- University of Oklahoma
- Start
- Nov 2022
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in postoperative pain comparing Gabapentin Arm with Placebo Arm (2 arms). Primary endpoint: Surgical Pain Scale (SPS) Score. Started Nov 2022; status: completed.
02
Drugs
gabapentin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05609682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05609682.